ChemicalBook >> CAS DataBase List >>Lupartumab

Lupartumab

Lupartumab structure

CAS No.: 1640971-88-5

Chemical Name:: Lupartumab

Synonyms: Lupartumab;BAY 1112623;Lupartumab (anti-LYPD3);Research Grade Lupartumab;Research Grade Lupartumab (DHB60001)

CBNumber:: CB58080993

Molecular Formula:

Molecular Weight:: 0

MDL Number:

MOL File:: Mol file

MSDS File:: SDS

TDS File:: TDS

Last updated:2026-04-24 14:59:10

Request For Quotation

Lupartumab Properties

form	Liquid
color	Colorless to light yellow
FDA UNII	WB2X681BC8

Lupartumab price

Manufacturer	Product number	Product description	CAS number	Packaging	Price	Updated	Buy
ChemScene	CS-0628978	Lupartumab 99.52%	1640971-88-5	1mg	$390	2026-06-04	Buy
ChemScene	CS-0628978	Lupartumab 99.52%	1640971-88-5	5mg	$1018	2026-06-04	Buy
ChemScene	CS-0628978	Lupartumab 99.52%	1640971-88-5	10mg	$1625	2026-06-04	Buy
aablocks	AA029JKE	Lupartumab ≥95%(SDS-PAGE&SEC-HPLC)	1640971-88-5	1mg	$576	2026-06-02	Buy
aablocks	AA029JKE	Lupartumab ≥95%(SDS-PAGE&SEC-HPLC)	1640971-88-5	5mg	$1510	2026-06-02	Buy

Product number	Packaging	Price	Buy
CS-0628978	1mg	$390	Buy
CS-0628978	5mg	$1018	Buy
CS-0628978	10mg	$1625	Buy
AA029JKE	1mg	$576	Buy
AA029JKE	5mg	$1510	Buy

Lupartumab Chemical Properties, Uses, Production

Uses

Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980[1].

References

[1] Willuda J, et al. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017 May;16(5):893-904. DOI:10.1158/1535-7163.MCT-16-0474

Lupartumab Preparation Products And Raw materials

Raw materials

Preparation Products

Lupartumab Suppliers

Global Suppliers ( 20)

Supplier	Tel	Email	Country	ProdList	Advantage
Shanghai YuanYe Biotechnology Co., Ltd.	15026964105	2881489226@qq.com	China	89667	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10305	58
Beijing Jin Ming Biotechnology Co., Ltd.	010-60605840	psaitong@jm-bio.com	China	27626	58
TargetMol Chemicals Inc.	4008200310 15002144251	marketing@tsbiochem.com	China	24951	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9864	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	7283	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11963	58
Wuhan Acumen Bio-Technology Co.,ltd	027-027-16602739303 16602739303	673003916@qq.com	China	4593	58
Changsha Fuzhen Biotechnology Co.，LTD	15111215862 18229892877	3062105966@qq.com	China	5568	58

Supplier	Advantage
Shanghai YuanYe Biotechnology Co., Ltd.	60
ShangHai Biochempartner Co.,Ltd	62
Wuhan Chemstan Biotechnology Co., Ltd.	58
Beijing Jin Ming Biotechnology Co., Ltd.	58
TargetMol Chemicals Inc.	58
Biolab Reagents	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	58
Shanghai Yifei Biotechnology Co. , Ltd.	58
Wuhan Acumen Bio-Technology Co.,ltd	58
Changsha Fuzhen Biotechnology Co.，LTD	58

1640971-88-5 (Lupartumab) Related Search:

Indatuximab Ravtansine Research Grade Acazicolcept (DHC83404) Perakizumab Murlentamab Teclistamab

Vanucizumab Icrucumab Vopratelimab Tarcocimab Romlusevimab

1of2

Lupartumab Research Grade Lupartumab (DHB60001) BAY 1112623 Research Grade Lupartumab Lupartumab (anti-LYPD3) 1640971-88-5